Literature DB >> 4285535

Replication in simian cells of defective viruses in an SV40-adenovirus "hybrid" population.

J S Butel, F Rapp.   

Abstract

Butel, Janet S. (Baylor University College of Medicine, Houston, Tex.), and Fred Rapp. Replication in simian cells of defective viruses in an SV40-adenovirus "hybrid" population. J. Bacteriol. 91:278-284. 1966.-An SV40-adenovirus type 7 "hybrid" virus population, previously shown to contain two viruses capable of complementation in green monkey kidney (GMK) cells, has a growth cycle in GMK cells similar to that of adenovirus type 7 in the presence of SV40. Extending previous preliminary results, the addition of adenovirus types 2, 7, or 12 to monolayers of GMK cells enhanced plaque formation by the SV40-adenovirus hybrid by as much as 200-fold. The terminal enhanced plaques, initiated by the hybrid in the presence of helper adenovirus, were found to contain progeny which could induce the synthesis of SV40 tumor antigen but which were coated with the protein of the helper adenovirus, type 2, 7, or 12, respectively. The particle carrying the SV40 tumor antigen determinant, named PARA, is defective in that it cannot direct the synthesis of capsid protein; information for the coat for PARA is supplied by the adenovirus. One-step growth curves of the hybrid virus population in monkey cells revealed that synthesis of both types of particles, adenovirus and PARA, proceeds at a similar rate, with a latent period of 16 to 20 hr being followed by an exponential increase in titer during the following 20 hr. Maximal titers for both particles were obtained 48 hr after inoculation of the cultures. Neither the PARA nor the adenovirus component replicated in GMK cells in the absence of the other.

Entities:  

Mesh:

Year:  1966        PMID: 4285535      PMCID: PMC315946          DOI: 10.1128/jb.91.1.278-284.1966

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  29 in total

1.  HOST-DEPENDENT MUTANTS OF THE BACTERIOPHAGE F2. II. RESCUE AND COMPLEMENTATION OF MUTANTS.

Authors:  R C VALENTINE; D L ENGELHARDT; N D ZINDER
Journal:  Virology       Date:  1964-06       Impact factor: 3.616

2.  ANALYSIS OF THE DEFECTIVENESS OF ROUS SARCOMA VIRUS, II. SPECIFICATION OF RSV ANTIGENICITY BY HELPER VIRUS.

Authors:  H HANAFUSA; T HANAFUSA; H RUBIN
Journal:  Proc Natl Acad Sci U S A       Date:  1964-01       Impact factor: 11.205

3.  SOURCE OF GENETIC INFORMATION FOR SPECIFIC COMPLEMENT-FIXING ANTIGENS IN SV40 VIRUS-INDUCED TUMORS.

Authors:  A B SABIN; M A KOCH
Journal:  Proc Natl Acad Sci U S A       Date:  1964-11       Impact factor: 11.205

4.  SYNTHESIS OF SV40 TUMOR ANTIGEN DURING REPLICATION OF SIMIAN PAPOVAVIRUS (SV40).

Authors:  F RAPP; T KITAHARA; J S BUTEL; J L MELNICK
Journal:  Proc Natl Acad Sci U S A       Date:  1964-11       Impact factor: 11.205

5.  VIRUS-INDUCED INTRANUCLEAR ANTIGEN IN CELLS TRANSFORMED BY PAPOVAVIRUS SV40.

Authors:  F RAPP; J S BUTEL; J L MELNICK
Journal:  Proc Soc Exp Biol Med       Date:  1964 Aug-Sep

6.  INDUCTION BY ADENOVIRUS TYPE 7 OF TUMORS IN HAMSTERS HAVING THE ANTIGENIC CHARACTERISTICS OF SV40 VIRUS.

Authors:  R J HUEBNER; R M CHANOCK; B A RUBIN; M J CASEY
Journal:  Proc Natl Acad Sci U S A       Date:  1964-12       Impact factor: 11.205

7.  THE INCORPORATION OF SV40 MATERIAL INTO ADENOVIRUS 7 AS MEASURED BY INTRANUCLEAR SYNTHESIS OF SV40 TUMOR ANTIGEN.

Authors:  F RAPP; J L MELNICK; J S BUTEL; T KITAHARA
Journal:  Proc Natl Acad Sci U S A       Date:  1964-12       Impact factor: 11.205

8.  PRODUCTION OF "TUMOR-SPECIFIC" ANTIGENS BY ONCOGENIC VIRUSES DURING ACUTE CYTOLYTIC INFECTIONS.

Authors:  M D HOGGAN; W P ROWE; P H BLACK; R J HUEBNER
Journal:  Proc Natl Acad Sci U S A       Date:  1965-01       Impact factor: 11.205

9.  THE NATURE AND LOCALIZATION OF THE SV 40-INDUCED COMPLEMENT-FIXING ANTIGEN.

Authors:  R V GILDEN; R I CARP; F TAGUCHI; V DEFEND
Journal:  Proc Natl Acad Sci U S A       Date:  1965-03       Impact factor: 11.205

10.  Transduction and segregation in Escherichia coli K12.

Authors:  A CAMPBELL
Journal:  Virology       Date:  1957-10       Impact factor: 3.616

View more
  15 in total

1.  Growth of SV 40, adeno 7 and SV 40-adeno 7 viruses in monkey and human cells at 29 degrees and 37 degrees C.

Authors:  L Kutinová
Journal:  Arch Virol       Date:  1975       Impact factor: 2.574

2.  Biological and biophysical characterization of SV40 cytoplasmic T-antigen-inducing mutants of PARA-adenovirus 7.

Authors:  M J Guentzel; J S Butel
Journal:  Arch Gesamte Virusforsch       Date:  1973

3.  Quantitative transformation of primate cells by PARA (defective SV40)-adenovirus type 7.

Authors:  S S Layne; R Duff; F Rapp
Journal:  Arch Gesamte Virusforsch       Date:  1972

4.  Enhancement of the replication of human adenoviruses in simian cells by simian adenovirus SV15.

Authors:  R F Naegele; F Rapp
Journal:  J Virol       Date:  1967-08       Impact factor: 5.103

5.  Polyribosomes of cells abortively or productively infected with adenovirus, papovavirus, or their hybrid.

Authors:  F Rapp; M J Guentzel
Journal:  Arch Gesamte Virusforsch       Date:  1969

6.  Characteristics of tobacco rattle virus. I. Evidence that its two particles are functionally defective and mutually complementing.

Authors:  H L Sänger
Journal:  Mol Gen Genet       Date:  1968-05-17

7.  Detection of biologically active adenovirions unable to plaque in human cells.

Authors:  J S Butel; J L Melnick; F Rapp
Journal:  J Bacteriol       Date:  1966-08       Impact factor: 3.490

8.  Characterization of simian cells tranformed by temperature-sensitive mutants of simian virus 40.

Authors:  C A Noonan; J S Brugge; J S Butel
Journal:  J Virol       Date:  1976-06       Impact factor: 5.103

9.  Replication and complementation of human adenoviruses and simian papovavirus at an elevated temperature.

Authors:  M Jerkofsky; F Rapp
Journal:  J Virol       Date:  1968-07       Impact factor: 5.103

10.  Variation in the oncogenic potential of human adenoviruses carrying a defective SV40 genome (PARA).

Authors:  F Rapp; M Jerkofsky; J L Melnick; B Levy
Journal:  J Exp Med       Date:  1968-01-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.